Read More Pharma Industry News How rare disease medicine access in Africa is moving from ad hoc supply to structured compliance-led programs How Veld Pharmaceuticals and Chiesi are reshaping rare disease drug access in Africa through compliance-led programs. Read what this means for the sector. bySoujanya RaviApril 15, 2026